Suppr超能文献

印度消除淋巴丝虫病——一项成功的努力。

Elimination of lymphatic filariasis in India--a successful endeavour.

作者信息

Srivastava P K, Dhillon G P S

机构信息

National Vector Borne Disease Control Programme, Ministry of Health and Family Welfare, Government of India, Delhi.

出版信息

J Indian Med Assoc. 2008 Oct;106(10):673-4, 676-7.

Abstract

World Health Assembly resolution in 1997 for elimination of lymphatic filariasis (ELF) by 2020 made all the filaria endemic countries in the world to put efforts for its elimination by progressively reducing and ultimately interrupting the transmission of lymphatic filariasis. National Health Policy, 2002 has set the goal for elimination of lymphatic filariasis (ELF) in India by the year 2015. In pursuit to achieve this goal, the strategy of mass drug administration (MDA) with annual single dose of diethylcarbamazine citrate (DEC) tablets was introduced in 2004 in all the filaria endemic states of the country and 202 districts were covered. Intensive information education and communication (IEC) and awareness campaign were organised and more districts were included for MDA in subsequent years after 2004.Presently 250 districts are covered under MDA. The coverage of population during MDA against eligible population in the country has been reported 73.19% in 2004, 71.54% in 2005, 60.92% in 2006 and 81.41% in 2007. The microfilaria (mf) rate estimated in sentinel and random sites of each filaria endemic district revealed that in 2007, 177 districts are with less than 1% mf rate and 73 districts are with more than 1%.

摘要

1997年世界卫生大会通过决议,要求到2020年消除淋巴丝虫病(ELF),这使得世界上所有丝虫病流行国家都努力通过逐步减少并最终阻断淋巴丝虫病的传播来实现消除目标。2002年的国家卫生政策设定了到2015年在印度消除淋巴丝虫病(ELF)的目标。为实现这一目标,2004年在该国所有丝虫病流行邦引入了每年单剂量服用枸橼酸乙胺嗪(DEC)片的群体服药策略(MDA),覆盖了202个县。开展了强化信息教育与沟通(IEC)及宣传活动,2004年后的后续几年纳入了更多县进行群体服药。目前有250个县实施群体服药。据报告,2004年群体服药覆盖的人口占该国符合条件人口的比例为73.19%,2005年为71.54%,2006年为60.92%,2007年为81.41%。在每个丝虫病流行县的哨点和随机地点估计的微丝蚴(mf)率显示,2007年,有177个县的mf率低于1%,73个县的mf率高于1%。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验